Get the Stockscreener App
14.53
18.61%
2.28
After Hours:
14.23
-0.30
-2.06%
Fortrea Holdings Inc stock is traded at $14.53, with a volume of 4.23M.
It is up +18.61% in the last 24 hours and up +53.76% over the past month.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
See More
Previous Close:
$12.25
Open:
$13.97
24h Volume:
4.23M
Relative Volume:
2.53
Market Cap:
$1.37B
Revenue:
$2.72B
Net Income/Loss:
$-986.20M
P/E Ratio:
-1.3318
EPS:
-10.91
Net Cash Flow:
$88.30M
1W Performance:
+35.04%
1M Performance:
+53.76%
6M Performance:
+21.59%
1Y Performance:
+145.03%
1-Day Range:
$13.96
$15.61
1-Week Range:
$10.43
$15.61
52-Week Range:
$3.97
$18.67
Fortrea Holdings Inc Stock (FTRE) Company Profile
Name
Fortrea Holdings Inc
Sector
Industry
Phone
877-495-0816
Address
8 MOORE DRIVE, DURHAM
Compare FTRE vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FTRE
Fortrea Holdings Inc
|
14.53 | 1.16B | 2.72B | -986.20M | 88.30M | -10.91 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 109.34B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 74.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 50.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 39.78B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.02B | 5.36B | 287.73M | 924.18M | 2.5229 |
Fortrea Holdings Inc Stock (FTRE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-09-26 | Upgrade | TD Cowen | Hold → Buy |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Jan-06-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-15-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Dec-11-25 | Upgrade | Citigroup | Neutral → Buy |
| Aug-04-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| May-02-25 | Initiated | Truist | Hold |
| Apr-10-25 | Downgrade | Barclays | Equal Weight → Underweight |
| Dec-11-24 | Downgrade | Citigroup | Buy → Neutral |
| Dec-06-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-25-24 | Downgrade | Jefferies | Buy → Hold |
| Aug-08-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Jul-24-24 | Resumed | Barclays | Equal Weight |
| Jun-06-24 | Initiated | Goldman | Neutral |
| May-29-24 | Initiated | TD Cowen | Hold |
| May-28-24 | Initiated | Mizuho | Neutral |
| Mar-22-24 | Initiated | Robert W. Baird | Neutral |
| Mar-06-24 | Initiated | Deutsche Bank | Hold |
| Jan-05-24 | Initiated | William Blair | Mkt Perform |
| Jan-04-24 | Initiated | Jefferies | Buy |
| Dec-11-23 | Upgrade | Citigroup | Neutral → Buy |
| Dec-01-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-14-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-19-23 | Initiated | Citigroup | Neutral |
| Sep-14-23 | Initiated | Evercore ISI | In-line |
| Aug-16-23 | Initiated | Barclays | Equal Weight |
| Aug-07-23 | Initiated | BofA Securities | Underperform |
View All
Fortrea Holdings Inc Stock (FTRE) Latest News
Fortrea Earnings Call: Margins Rise Amid Revenue Pressure - TipRanks
Fortrea : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) - marketscreener.com
Fortrea reiterates 2026 revenue of $2.55B-$2.65B amid $190M-$220M adjusted EBITDA target - MSN
[10-Q] Fortrea Holdings Inc. Quarterly Earnings Report - Stock Titan
Fortrea Q1 Earnings Call Highlights - MarketBeat
Fortrea Holdings Inc. (FTRE) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Evercore ISI raises Fortrea stock price target on execution improvements By Investing.com - Investing.com South Africa
Fortrea Holdings Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Fortrea (FTRE) Shares Skyrocket, What You Need To Know - Barchart
Fortrea (FTRE) Q1 2026 Earnings Transcript - The Globe and Mail
Fortrea (NASDAQ:FTRE) Shares Gap Up After Better-Than-Expected Earnings - MarketBeat
Fortrea Shares Rise After Q1 Beat - marketscreener.com
Fortrea (NASDAQ:FTRE) Releases Quarterly Earnings Results, Beats Estimates By $0.13 EPS - MarketBeat
Fortrea Q1 2026 slides: margins expand 270 bps amid cost cuts - Investing.com
Fortrea Holdings 1Q Loss $23.6M >FTRE - Moomoo
Earnings call transcript: Fortrea Holdings beats Q1 2026 EPS forecast amid revenue decline - Investing.com
Fortrea Holdings Releases Q1 2026 Financial Results - AlphaStreet
Fortrea Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Fortrea Holdings Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:FTRE) 2026-05-05 - Seeking Alpha
Fortrea (NASDAQ:FTRE) Beats on Q1 Profit but Revenue Miss Caps Gains - ChartMill
Fortrea Holdings Inc. (FTRE) Beats Q1 Earnings Estimates - Yahoo Finance Australia
Earnings Flash (FTRE) Fortrea Holdings Inc. Reports Q1 Revenue $636.5M, vs. FactSet Est of $627.4M - marketscreener.com
Earnings Flash (FTRE) Fortrea Holdings Inc. Posts Q1 Adjusted EPS $0.16 per Share, vs. FactSet Est of $0.05 - marketscreener.com
Fortrea’s (NASDAQ:FTRE) Q1 CY2026 Sales Beat Estimates, Stock Soars - Yahoo Finance
Fortrea : Q1'26 Earnings Presentation - marketscreener.com
Fortrea (Nasdaq: FTRE) lifts Q1 adjusted earnings and backs 2026 outlook - Stock Titan
FTRE: Q1 2026 delivered strong adjusted earnings and bookings, with guidance reaffirmed for the year - TradingView
Fortrea books more work than it billed for third straight quarter - Stock Titan
Fortrea Reports First Quarter 2026 Results - The Manila Times
Fortrea earnings up next: Recovery test after analyst downgrades By Investing.com - Investing.com South Africa
Fortrea earnings up next: Recovery test after analyst downgrades - Investing.com
Fortrea (FTRE) Q1 Earnings: What To Expect - Yahoo Finance
Johnson Fistel, PLLP Begins Investigation on Behalf of - GlobeNewswire
Fortrea Holdings Inc. (NASDAQ:FTRE) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Mizuho cuts Fortrea stock price target to $13 on lower estimates - Investing.com
Do Fortrea Holdings' (FTRE) Shrinking Sales Reveal Deeper Strains In Its Growth Strategy? - simplywall.st
Fortrea Holdings (FTRE) price target decreased by 10.45% to 13.11 - MSN
Vanguard holds 4.73M shares in Fortrea Holdings (NASDAQ: FTRE) in 13G filing - Stock Titan
Fortrea (FTRE) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Fortrea Holdings Inc. (FTRE) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Implied volatility surging for Fortrea Holdings stock options - MSN
Fortrea upgraded at Evercore ISI on management changes - MSN
[ARS] Fortrea Holdings Inc. SEC Filing - Stock Titan
Fortrea (NASDAQ: FTRE) sets 2026 director, auditor and Say-on-Pay votes - Stock Titan
Fortrea (FTRE) Q3 2024 earnings summary - Quartr
Fortrea (NASDAQ:FTRE) Stock Price Down 10%What's Next? - MarketBeat
What is driving Fortrea Holdings (FTRE) stock | Q4 2025: EPS Misses EstimatesNet Margin - Cổng thông tin điện tử tỉnh Lào Cai
Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call - marketscreener.com
Fortrea Holdings Inc Stock (FTRE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.14%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):